Experimental Pathology Laboratory Advisory Committee (EPLAC)
 

  • Proposed Projects

  • Projects in Progress

  • Meeting Minutes

  • Data & Statistics

EPL Advisory Committee (EPLAC)

  • Frederic Barr, MD, PhD (Chair)
  • Elaine S. Jaffe, MD
  • David Levens, MD, PhD
  • Mark Raffeld, MD
  • Markku Miettinen, MD
  • Stephen Hewitt, MD, PhD (ex-officio member)
  • Joseph W. Chinquee, DHSc, MBA (ex-officio member)

Overview

EPLAC will serve in an advisory role to the LP leadership regarding the management, oversight and accounting of the EPL.

Requests for EPL projects are evaluated by the EPLAC based on:

–  Level of collaboration

–  Translational potential

–  Team involvement

–  Congruence with defined LP themes

The effectiveness of the EPL will be reviewed on an semi-annual basis by LP leadership with EPLAC input

–    EPLAC Membership

  • LP Leadership (2), PIs (2), Clinical Unit Heads (2), (EPL head will be ex officio member)
  • 2 year terms, staggered
  • LP Leadership have chosen the inaugural group (for sake of timeliness of implementation)

–      Support to establish systems for monitoring usage of EPL resources

Forms:

IHC request
IHC request-Dr. Kleiner
CISH request
Antibody Inventory
Last updated by Chinquee, Joseph (NIH/NCI) [E] on Dec 30, 2017